BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, Taherkhani S, Nejadbolkheyr A. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. PLoS One. 2016;11:e0157615. [PMID: 27309959 DOI: 10.1371/journal.pone.0157615] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses. Sci Rep. 2018;8:150. [PMID: 29317673 DOI: 10.1038/s41598-017-18296-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
2 Niazkar HR, Dorgalaleh A, Rad F. First-time Blood Donors Are Double-edged Swords for Blood Transfusion Centers: A Retrospective Study in Southwest Iran. Turk J Haematol 2020;37:30-5. [PMID: 31475800 DOI: 10.4274/tjh.galenos.2019.2019.0166] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Farshadpour F, Taherkhani R, Bakhtiari F. Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran. Biomed Res Int 2021;2021:9294276. [PMID: 34589552 DOI: 10.1155/2021/9294276] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Biadgo B, Shiferaw E, Woldu B, Alene KA, Melku M. Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study. PLoS One 2017;12:e0180416. [PMID: 28678865 DOI: 10.1371/journal.pone.0180416] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
5 Keleta YT, Achila OO, Haile AW, Gebrecherkos BH, Tesfaldet DT, Teklu KS, Mohammed MA, Ghedel ST. Seroprevalence of transfusion transmitted infections among blood donors in Gash Barka Zonal Blood Transfusion Center, Barentu, Eritrea, 2014 through 2017. BMC Hematol 2019;19:5. [PMID: 30911398 DOI: 10.1186/s12878-019-0136-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Deressa T, Birhan W, Enawgaw B, Abebe M, Baynes HW, Desta M, Terefe B, Melku M. Proportion and predictors of transfusion-transmissible infections among blood donors in North Shewa Zone, Central North Ethiopia. PLoS One 2018;13:e0194083. [PMID: 29579055 DOI: 10.1371/journal.pone.0194083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
7 Mierzejewski B, Archacka K, Grabowska I, Florkowska A, Ciemerych MA, Brzoska E. Human and mouse skeletal muscle stem and progenitor cells in health and disease. Semin Cell Dev Biol 2020;104:93-104. [PMID: 32005567 DOI: 10.1016/j.semcdb.2020.01.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
8 Siraj N, Achila OO, Issac J, Menghisteab E, Hailemariam M, Hagos S, Gebremeskel Y, Tesfamichael D. Seroprevalence of transfusion-transmissible infections among blood donors at National Blood Transfusion Service, Eritrea: a seven-year retrospective study. BMC Infect Dis 2018;18:264. [PMID: 29879912 DOI: 10.1186/s12879-018-3174-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
9 Wu D, Feng F, Wang X, Wang D, Hu Y, Yu Y, Huang J, Wang M, Dong J, Wu Y, Zhu H, Zhu F. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review. BMC Infect Dis 2022;22:279. [PMID: 35321684 DOI: 10.1186/s12879-022-07279-5] [Reference Citation Analysis]
10 Pessoni LL, Aquino ÉC, Alcântara KC. Prevalence and trends in transfusion-transmissible infections among blood donors in Brazil from 2010 to 2016. Hematol Transfus Cell Ther 2019;41:310-5. [PMID: 31409582 DOI: 10.1016/j.htct.2019.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Taherkhani R, Farshadpour F. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World J Hepatol 2017; 9(33): 1239-1252 [PMID: 29312527 DOI: 10.4254/wjh.v9.i33.1239] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
12 Beykaso G, Teklehaymanot T, Giday M, Berhe N, Doyore F, Alemayehu DH, Mihret A, Mulu A. Estimating the Transmission Risks of Viral Hepatitis and HIV Among Blood Donors in Hossana, Southern Ethiopia. Risk Manag Healthc Policy 2021;14:3117-27. [PMID: 34335061 DOI: 10.2147/RMHP.S323057] [Reference Citation Analysis]
13 Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman. Asian Pac J Cancer Prev 2017;18:3267-72. [PMID: 29286218 DOI: 10.22034/APJCP.2017.18.12.3267] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Aghsami A, Samimi Y, Aghaei A. A novel Markovian queueing-inventory model with imperfect production and inspection processes: A hospital case study. Computers & Industrial Engineering 2021;162:107772. [DOI: 10.1016/j.cie.2021.107772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sharew B, Mulu A, Teka B, Tesfaye T. HIV-Sero-prevalence trend among blood donors in North East Ethiopia. Afr Health Sci 2017;17:712-8. [PMID: 29085398 DOI: 10.4314/ahs.v17i3.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
16 Melku M, Ambachew S, Enawgaw B, Abebe M, Abebe Z, Deressa T, Damtie D, Biadgo B, Tessema B, Geremew D, Kebede A, Woldu B, Teklu T, Shiferaw E. Sero-epidemiology and associated factors of HIV, HBV, HCV and syphilis among blood donors in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis 2021;21:778. [PMID: 34372772 DOI: 10.1186/s12879-021-06505-w] [Reference Citation Analysis]
17 Wahid B, Saleem K, Rasool N, Rafique S, Ali A, Waqar M, Idrees M. Tattooing trend: major cause of HCV transmission among youngsters. Infect Dis (Lond) 2018;50:871-3. [PMID: 30317901 DOI: 10.1080/23744235.2018.1518586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Nlankpe AM, Kwadzokpui PK, Adedia D, Nignan JN, Owiafe PK. Seroepidemiology of Hepatitis B and C Virus Infections: A Five-Year Retrospective Study among Blood Donors in Saboba District in the Northern Region of Ghana. Biomed Res Int 2021;2021:5599705. [PMID: 34055986 DOI: 10.1155/2021/5599705] [Reference Citation Analysis]
19 Damola AB, Adeniji JA, Bakarey AS. Hepatitis C virus seropositivity and the risk factors for transmission among blood donors in some selected centers in Lagos State, Southwest Nigeria. J Immunoassay Immunochem 2019;40:528-39. [PMID: 31378189 DOI: 10.1080/15321819.2019.1647853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Taherkhani R, Farshadpour F. Lurking epidemic of hepatitis C virus infection in Iran: A call to action. World J Hepatol 2017; 9(24): 1040-1042 [PMID: 28932350 DOI: 10.4254/wjh.v9.i24.1040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
21 Vasmehjani AA, Yaghubi S, Erfani Y, Hajikhezri Z, Farahmand M, Shayestehpour M, Adeli OA, Beiranvand M. Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven-year of Experience in Lorestan, Iran. Int J Prev Med 2020;11:178. [PMID: 33456734 DOI: 10.4103/ijpvm.IJPVM_260_18] [Reference Citation Analysis]
22 Azadbakht M, Ardakani MT, Delirakbariazar M, Kasraian L, Khaledi A, Foruozandeh H, Salah A, Maleki F, Eshraghi M. Seroprevalence and Trend of HBV, HCV, and HIV Infections among Blood Donors of Fars Province, Iran (2006-2018). Ethiop J Health Sci 2020;30:397-408. [PMID: 32874083 DOI: 10.4314/ejhs.v30i3.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Cuypers L, Thijssen M, Shakibzadeh A, Deboutte W, Sarvari J, Sabahi F, Ravanshad M, Pourkarim MR. Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran. Infect Genet Evol 2019;75:103966. [PMID: 31323326 DOI: 10.1016/j.meegid.2019.103966] [Reference Citation Analysis]
24 Saba N, Nasir JA, Waheed U, Aslam S, Mohammad I, Wazeer A, Ahmed S, Nisar M. Seroprevalence of Transfusion-Transmitted Infections among Voluntary and Replacement Blood Donors at the Peshawar Regional Blood Centre, Khyber Pakhtunkhwa, Pakistan. J Lab Physicians 2021;13:162-8. [PMID: 34483564 DOI: 10.1055/s-0041-1729485] [Reference Citation Analysis]
25 Samje M, Fondoh VN, Nguefack-Tsague G, Kamalieuk LKJ, Mbanya D, Murphy EL, Tagny CT. Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, Cameroon. Transfus Clin Biol 2021;28:228-33. [PMID: 34102320 DOI: 10.1016/j.tracli.2021.05.011] [Reference Citation Analysis]
26 Lokpo SY, Dakorah MP, Norgbe GK, Osei-Yeboah J, Adzakpah G, Sarsah I, Gameli Deku J, Afeke I, Akomanin Asiamah E, Manaphraim NYB, Asare I, Ayidzoe BJ, Alote Allotey E, Nani EA, Amoah P. The Burden and Trend of Blood-Borne Pathogens among Asymptomatic Adult Population in Akwatia: A Retrospective Study at the St. Dominic Hospital, Ghana. J Trop Med 2017;2017:3452513. [PMID: 29181037 DOI: 10.1155/2017/3452513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Fite RO, Kooti W, Azeze GA, Tesfaye B, Hagisso SN. Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis. Arch Virol 2020;165:1039-48. [PMID: 32219546 DOI: 10.1007/s00705-020-04591-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Omidkhoda A, Razi B, Arabkhazaeli A, Amini Kafi-Abad S. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety. BMC Infect Dis 2020;20:736. [PMID: 33028232 DOI: 10.1186/s12879-020-05405-9] [Reference Citation Analysis]
29 Aabdien M, Selim N, Himatt S, Hmissi S, Merenkov Z, AlKubaisi N, Abdel-Rahman ME, Abdelmola A, Khelfa S, Farag E, Al-Romaihi HE, Al-Thani M, Derbala M, Al-Kaabi S. Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013-2017. BMC Infect Dis 2020;20:617. [PMID: 32819294 DOI: 10.1186/s12879-020-05344-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Valerian DM, Mauka WI, Kajeguka DC, Mgabo M, Juma A, Baliyima L, Sigalla GN. Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania. PLoS One 2018;13:e0206487. [PMID: 30359434 DOI: 10.1371/journal.pone.0206487] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
31 Farshadpour F, Taherkhani R, Ravanbod MR, Eghbali SS. Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes Mellitus. Med Princ Pract 2018;27:308-16. [PMID: 29621783 DOI: 10.1159/000488985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Eko Mba JM, Bisseye C, Ntsame Ndong JM, Mombo LE, Bengone C, Mouelet Migolet G, M'batchi B, Kosiorek HE, Butterfield RJ, Roberts LR, Borad MJ, Nagalo BM. Prevalent hepatitis B surface antigen among first-time blood donors in Gabon. PLoS One 2018;13:e0194285. [PMID: 29652917 DOI: 10.1371/journal.pone.0194285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Emadi B, Ghahraman Rezaieh M, Sedighi M. Seroprevalence and trends of transfusion transmissible infections among retrospective blood donors in Western Azerbaijan Regional Blood Transfusion Center, Iran: A ten-years evaluation. Transfus Apher Sci 2021;60:103132. [PMID: 33846093 DOI: 10.1016/j.transci.2021.103132] [Reference Citation Analysis]
34 Pinto CS, Costa GB, Allaman IB, Gadelha SR. Clinical, epidemiological aspects, and trends of Hepatitis B in Brazil from 2007 to 2018. Sci Rep 2021;11:13986. [PMID: 34234226 DOI: 10.1038/s41598-021-93434-y] [Reference Citation Analysis]
35 Negash M, Ayalew M, Geremew D, Workineh M. Seroprevalence and associated risk factors for HIV, Hepatitis B and C among blood Donors in South Gondar District blood Bank, Northwest Ethiopia. BMC Infect Dis 2019;19:430. [PMID: 31096921 DOI: 10.1186/s12879-019-4051-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
36 Corrêa ASM, Lamarão LM, Vieira PCM, de Castro RBH, de Almeida NCC, de Castro JAA, de Lima MSM, Palmeira MK, Meireles ALLP, Burbano RR. Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil. PLoS One 2018;13:e0208414. [PMID: 30566494 DOI: 10.1371/journal.pone.0208414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]